1188 Antibody substrate oligonucleotide conjugates (ASOCs): a new class of immunotherapeutic agents to inhibit metastasis of tumor cells and block checkpoint inhibition | Zendy

AI Assistant Blog Pricing

1188 Antibody substrate oligonucleotide conjugates (ASOCs): a new class of immunotherapeutic agents to inhibit metastasis of tumor cells and block checkpoint inhibition

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.